¿Qué hay de nuevo en el síndrome de ovario poliquístico? / Whats new in polycystic ovary syndrome
Rev. chil. endocrinol. diabetes
;
6(2): 69-75, abr. 2013. ilus
Article
Dans Espagnol
| LILACS
| ID: lil-726577
ABSTRACT
Polycystic ovary syndrome is recognized as a risk factor for the development of type 2 diabetes and metabolic syndrome. The prevalence of the condition is 6 to 10 percent in different populations. Its etiology is not well known and there are genetic and epigenetic phenomena involved. Due to its association with insulin resistance, it has been incorporated as another component of Reaven plurimetabolic syndrome. Therefore polycystic ovary syndrome evolved from an ovarian disease to a multisystem disorder and it must be considered a public health problem.
Texte intégral:
Disponible
Indice:
LILAS (Amériques)
Sujet Principal:
Syndrome des ovaires polykystiques
Type d'étude:
Facteurs de risque
Limites du sujet:
Femelle
/
Humains
langue:
Espagnol
Texte intégral:
Rev. chil. endocrinol. diabetes
Thème du journal:
Endocrinologie
Année:
2013
Type:
Article
/
descriptif de projet
Pays d'affiliation:
Chili
Institution/Pays d'affiliation:
Hospital San Juan de Dios/CL
/
Universidad de Chile/CL
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS